Skip to main content

Latest SEC Filings — Page 133

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

Diana Shipping Withdraws Four Director Nominees in Genco Proxy Fight
ProForm DEFA14AGNK · Form DEFA14A · 2026-06-10
Iovance Secures Australian Amtagvi Approval, Authorizes Significant Share Increase
ProForm 8-KIOVA · Form 8-K · 2026-06-10
SPAC Seeks Extension to Avoid Liquidation; Redemption Price Above Market
ProForm DEF 14ALPAA · Form DEF 14A · 2026-06-10
J&J Snack Foods Extends Credit Facility to 2031, Gains $200M Expansion Option, General Counsel Resigns
ProForm 8-KJJSF · Form 8-K · 2026-06-10
American Eagle Extends $700M Revolving Credit Facility to 2031
ProForm 8-KAEO · Form 8-K · 2026-06-10
Sadot Group Amends Acquisition Terms, Removes Dilution Risk from Preferred Stock and Promissory Note
ProForm 8-KSDOT · Form 8-K · 2026-06-10
Netcapital Secures $111K in High-Cost, Highly Dilutive Convertible Debt and Warrants
ProForm 8-KNCPL · Form 8-K · 2026-06-10
Baosheng Media Secures $12.5M in Highly Dilutive PIPE Offering at Deep Discount, Addressing Going Concern
ProForm 6-KBAOS · Form 6-K · 2026-06-10
American Airlines Stockholders Approve 16.5M Share Increase for Incentive Plan, Reject Officer Liability Limit
ProForm 8-KAAL · Form 8-K · 2026-06-10
Former Officer & 10% Owner Sells $483K in Shares, Reduces Stake Amidst Going Concern Warning
ProForm SCHEDULE 13D/ARMCF · Form SCHEDULE 13D/A · 2026-06-10
Nixxy Announces Binding LOI for $1B AI Infrastructure Buildout and $5B GPU Financing, Pivoting to AI Energy Platform
ProForm 8-KNIXX · Form 8-K · 2026-06-10
WhiteHawk Minerals Completes IPO, Internalizes Management, and Appoints New Executive Team
ProForm 8-KWHK · Form 8-K · 2026-06-10
Terra Property Trust Amends & Extends Distressed Debt Exchange Offer for $54.5M Notes
ProForm S-4/ATPTA · Form S-4/A · 2026-06-10
Shareholders Approve Massive Dilution, Enabling Resale of 24.87M Shares; Company to Rebrand as Faeth Therapeutics
ProForm S-3/ASNSE · Form S-3/A · 2026-06-10
Former Director Michael Chernoff Files to Sell Additional $1.26M in Stock, Continuing Recent Distribution
Form 144VTS · Form 144 · 2026-06-10
Clear Secure Stockholders Approve Removal of Supermajority Vote Requirements
Form 8-KYOU · Form 8-K · 2026-06-10
Director-Affiliated Entity Canaan VIII LP Files to Sell Another $13M in Liquidia Stock
ProForm 144LQDA · Form 144 · 2026-06-10
Figure Technology Solutions to Acquire Kiavi for $532M, Secures $600M Bridge Loan
ProForm 8-KFIGR · Form 8-K · 2026-06-10
HNI Refinances $498.75M Term Loan, Securing Lower Interest Rates
Form 8-KHNI · Form 8-K · 2026-06-10
Biogen Reclassifies Apellis Acquisition as Non-Significant, Removes Pro Forma Financial Requirement
Form 8-K/ABIIB · Form 8-K/A · 2026-06-10
Parabilis Medicines Prices Upsized $670M IPO and Concurrent $75M Private Placement
ProForm 424B4PBLS · Form 424B4 · 2026-06-10
Court Dismisses Securities Class Action; Stibnite Project Lawsuit Proceeds to Summary Judgment Hearing
Form 8-KPPTA · Form 8-K · 2026-06-10
Einride Completes Business Combination, Commences Trading on Nasdaq Under 'ENRD'
ProForm 6-KENRD · Form 6-K · 2026-06-10
VivoPower Details AI Data Center Strategy, 3.3GW Pipeline, and Geopolitical Delay for $115M Private Placement
ProForm 6-KVIVO · Form 6-K · 2026-06-10
Mercury General Finalizes $525M Senior Notes Offering to Refinance Debt
ProForm 424B5MCY · Form 424B5 · 2026-06-10
Anterix Reports Strong FY2026 Results: $90.6M Net Income, Increased Cash, and New Spectrum Deals
ProForm 8-KATEX · Form 8-K · 2026-06-10
Swarmer Files S-1 for Highly Dilutive $181M At-The-Market Offering
ProForm S-1SWMR · Form S-1 · 2026-06-10
Humacyte Announces Preliminary Underwritten Public Offering Following Positive Phase 3 Results
Form 424B5HUMA · Form 424B5 · 2026-06-10
Credit Acceptance Appoints Joseph Billante as New CFO; Jay Martin to Retire
Form 8-KCACC · Form 8-K · 2026-06-10
Shareholders Approve SPAC Extension, Averting Liquidation Deadline
ProForm 425PCSC · Form 425 · 2026-06-10